Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: Pharmacological tools and endogenous modulators

Trends in Pharmacological Sciences

Volumn 36, Issue 2, 2015, Pages 109-123

  Tsetlin, Victor I ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

acetylcholine receptors; Lynx1; neurotoxins; nicotinic

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA BUNGAROTOXIN; ALPHA NEUROTOXIN; BUNGAROTOXIN RECEPTOR; CANDOXIN; COBROTOXIN; EPIBATIDINE; ERABUTOXIN A; G PROTEIN COUPLED RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; HADITOXIN; IRDITOXIN; LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN 1; LYMPHOCYTE ANTIGEN 6; NEUROTOXIN; NICOTINIC RECEPTOR; SHAKER POTASSIUM CHANNEL; SNAKE VENOM; UNCLASSIFIED DRUG; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NEUROPEPTIDE;

AMINO ACID SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGAND BINDING; LYMNAEA STAGNALIS; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SLURP GENE; SNAKE; TORPEDO CALIFORNICA; TOXIN STRUCTURE; UPREGULATION; X RAY SPECTROMETRY; ANIMAL; CHEMISTRY; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; GPI-LINKED PROTEINS; NEUROPEPTIDES; NEUROTOXINS; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, NICOTINIC; SNAKE VENOMS;

EID: 84922212251     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.11.003     Document Type: Review

References (103)

1. V. Tsetlin Snake venom α-neurotoxins and other 'three-finger' proteins Eur. J. Biochem. 264 1999 281 286
2. S. Nirthanan Non-conventional toxins from Elapid venoms Br. J. Pharmacol. 139 2003 832 844
3. Y.N. Utkin Three-finger toxins, a deadly weapon of elapid venom: milestones of discovery Toxicon 62 2013 50 55
4. J.R. de Weille Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel Proc. Natl. Acad. Sci. U.S.A. 88 1991 2437 2440
5. S. Diochot Black mamba venom peptides target acid-sensing ion channels to abolish pain Nature 490 2012 552 555
6. A.G. Konshinna Structure and dynamics of cardiotoxins Curr. Protein Pept. Sci. 13 2012 570 584
7. M. Harel Crystal structure of an acetylcholineterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target Structure 3 1995 1355 1366
8. J.H. Shiu Solution structure of gamma-bungarotoxin: the functional significance of amino acid residues flanking the RGD motif in integrin-binding Proteins 57 2004 839 849
9. Y.N. Utkin Weak toxin from Naja kaouthia is a nontoxic antagonist of alpha 7 and muscle-type nicotinic acetylcholine receptors J. Biol. Chem. 276 2001 15810 15815
10. S. Nirthanan Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (alphabetagammadelta) but a poorly reversible antagonist of neuronal alpha 7 nicotinic acetylcholine receptors J. Biol. Chem. 277 2002 17811 17820
11. M. Ploug Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor Rev. Curr. Pharm. Des. 9 2003 1499 1528
12. A. Galat Conserved structural determinants in three-fingered protein domains FEBS J. 275 2008 3207 3225
13. P.Y. Lee Ly6 family proteins in neutrophil biology J. Leukoc. Biol. 94 2013 585 594
14. Y. Tirosh Short toxin-like proteins attack the defense line of innate immunity Toxins 5 2013 1314 1331
15. C.C. Chang, and C.Y. Lee Isolation of neurotoxins from the venom of Bungarus multicinctus and their modes of neuromuscular blocking action Arch. Int. Pharmacodyn. Ther. 144 1963 241 257
16. D. Tsernoglou, and G.A. Petsko The crystal structure of a post-synaptic neurotoxin from sea snake at A resolution FEBS Lett. 68 1976 1 4
17. B.W. Low Three dimensional structure of erabutoxin b neurotoxic protein: inhibitor of acetylcholine receptor Proc. Natl. Acad. Sci. U.S.A. 73 1976 2991 2994
18. M.V. Skok Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines Mol. Pharmacol. 64 2003 885 889
19. G. Gergalova Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria PLoS ONE 7 2012 e31361
20. A. Alama Inhibition of the nicotinic acetylcholine receptors by cobra venom α-neurotoxins: is there a perspective in lung cancer treatment? PLoS ONE 6 2011 e20695
21. J.M. McIntosh Alpha9 nicotinic acetylcholine receptors and the treatment of pain Biochem. Pharmacol. 78 2009 693 702
22. J.C. Dewan Crystal structure of κ-bungarotoxin at 2.3-A resolution Biochemistry 33 1994 13147 13154
23. V.A. Chiappinelli Binding of native κ-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors Toxicon 34 1996 1243 1256
24. G.A. Grant Differential roles for disulfide bonds in the structural integrity and biological activity of κ-bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist Biochemistry 37 1998 12166 12171
25. A. Roy Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra) J. Biol. Chem. 285 2010 8302 8315
26. A.V. Osipov Naturally occurring disulfide-bound dimers of three-fingered toxins: a paradigm for biological activity diversification J. Biol. Chem. 283 2008 14571 14580
27. A.V. Osipov Dimeric α-cobratoxin X-ray structure: localization of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptors J. Biol. Chem. 287 2012 6725 6734
28. J. Pawlak Irditoxin, a novel covalently linked heterodimeric three-finger toxin with high taxon-specific neurotoxicity FASEB J. 23 2009 534 545
29. B.G. Fry Molecular evolution and phylogeny of elapid snake venom three-finger toxins J. Mol. Evol. 57 2003 110 129
30. A.Y. Ogay Weak neurotoxin from Naja kaouthia cobra venom affects haemodynamic regulation by acting on acetylcholine receptors Toxicon 45 2005 93 99
31. D.Y. Mordvintsev Behavioural effects in mice and intoxication symptomatology of weak neurotoxin from cobra Naja kaouthia Basic Clin. Pharmacol. Toxicol. 100 2007 273 278
32. D.Y. Mordvintsev Weak toxin WTX from Naja kaouthia cobra venom interacts with both nicotinic and muscarinic acetylcholine receptors FEBS J. 276 2009 5065 5075
33. A.B. Smit A glia-derived acetylcholine-binding protein that modulates synaptic transmission Nature 411 2001 261 268
34. K. Brejc Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors Nature 411 2001 269 276
35. P. Rucktooa Insight in nAChR subtype selectivity from AChBP crystal structures Biochem. Pharmacol. 78 2009 777 787
36. V. Tsetlin Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors Biochem. Pharmacol. 78 2009 720 731
37. M. Nys Structural insights into Cys-loop receptor function and ligand recognition Biochem. Pharmacol. 86 2013 1042 1053
38. Y. Bourne Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors EMBO J. 24 2005 1512 1522
39. J-P. Changeux The nicotinic acetylcholine receptor: the founding father of the pentameric ligand-gated ion channel superfamily J. Biol. Chem. 287 2012 40207 40215
40. C.D. Dellisanti Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 Å resolution Nat. Neurosci. 10 2007 953 962
41. P.H. Celie Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors J. Biol. Chem. 280 2005 26457 26466
42. P.H. Celie Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant Nat. Struct. Mol. Biol. 12 2005 582 588
43. N. Unwin Refined structure of the nicotinic acetylcholine receptor at 4A resolution J. Mol. Biol. 346 2005 967 989
44. S.X. Li Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist Nat. Neurosci. 14 2011 1253 1259
45. S. Huang Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera Biochem. J. 454 2013 303 310
46. S.M. Sine Inter-residue coupling contributes to high-affinity subtype-selective binding of α-bungarotoxin to nicotinic receptors Biochem. J. 454 2013 311 321
47. A. Galat Common structural traits for cystine knot domain of the TGFβ superfamily of proteins and three-fingered ectodomain of their cellular receptors Cell. Mol. Life Sci. 68 2011 3437 3451
48. A.V. Osipov The first representative of glycosylated three-fingered toxins. Cytotoxin from the Naja kaouthia cobra venom Eur. J. Biochem. 271 2004 2018 2027
49. A. Galat Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands Cell. Mol. Life Sci. 70 2013 3243 3275
50. A. Müller Selective and programmed cleavage of GPI-anchored proteins from the surface membrane by phospholipase C Biochim. Biophys. Acta 1818 2012 117 124
51. H. Xiaotong GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy Clin. Exp. Metastasis 19 2002 291 299
52. J.M. Miwa Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS Neuron 23 1999 105 114
53. N. Moser Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures J. Neurochem. 102 2007 479 492
54. R.L. Parker Modulation of dopaminergic neuron function through lynx1/α6 nAChR interactions Neuroscience 2013 November 9-13, 2013, San Diego (http://wwww.abstractsonline.com)
55. I. Ibañez-Tallon Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1 Neuron. 33 2002 893 903
56. J.M. Miwa The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo Neuron 51 2006 587 600
57. R.E. Reiter Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer Proc. Natl. Acad. Sci. U.S.A. 95 1998 1735 1740
58. M. Hruska Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes alpha7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons J. Neurosci. 29 2009 14847 14854
59. Y.M. Choo Pr-lynx1, a modulator of nicotinic acetylcholine receptors in the insect Mol. Cell. Neurosci. 38 2008 224 235
60. Z. Liu Identification of two Lynx proteins in Nilaparvata lugens and the modulation on insect nicotinic acetylcholine receptors J. Neurochem. 110 2009 1707 1714
61. M. Darvas Modulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6 Eur. Neuropsychopharmacol. 19 2009 670 681
62. M. Wu SLEEPLESS is a bifunctional regulator of excitability and cholinergic synaptic transmission Curr. Biol. 24 2014 621 629
63. F. Levitin PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity J. Biol. Chem. 283 2008 16928 16939
64. K. Adermann Structural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamily Protein Sci. 8 1999 810 819
65. F. Chimienti Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda Hum. Mol. Genet. 12 2003 3017 3024
66. J. Arredondo SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium J. Cell. Physiol. 208 2006 238 245
67. K.M. Eckl Mal de Meleda (MDM) caused by mutations in the gene for SLURP-1 in patients from Germany, Turkey, Palestine, and the United Arab Emirates Hum. Genet. 112 2003 50 56
68. Y. Moriwaki Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands Life Sci. 80 2007 2365 2368
69. T. Fujii SLURP-1, an endogenous α7 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity J. Neuroimmunol. 267 2014 43 49
70. M. Bchetnia Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region Biomed Res. Int. 2013 2013 206803
71. O. Narumoto Effect of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1) on airway epithelial cells Biochem. Biophys. Res. Commun. 438 2013 175 179
72. H. Matsumoto Localization of acetylcholine-related molecules in the retina: implication of the communication from photoreceptor to retinal pigment epithelium PLoS ONE 7 2012 e42841
73. I. Ibañez-Tallon Tethering naturally occurring peptide toxins for cell-autonomous modulation of ion channels and receptors in vivo Neuron 43 2004 305 311
74. S. Auer, and I. Ibañez-Tallon 'The King is dead': checkmating ion channels with tethered toxins Toxicon 56 2010 1293 1298
75. S. Auer Silencing neurotransmission with membrane-tethered toxins Nat. Methods 7 2010 229 236
76. A.B. Tekinay A role for LYNX2 in anxiety-related behavior Proc. Natl. Acad. Sci. U.S.A. 106 2009 4477 4482
77. J.M. Miwa Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses Neuron 70 2011 20 33
78. I. Ibañez-Tallon, and M.N. Nitabach Tethering toxins and peptide ligands for modulation of neuronal function Curr. Opin. Neurobiol. 22 2012 72 78
79. J.M. Miwa Optimizing cholinergic tone through lynx modulators of nicotinic receptors: implications for plasticity and nicotine addiction Physiology 27 2012 187 199
80. H. Morishita Lynx1, a cholinergic brake, limits plasticity in adult visual cortex Science 330 2010 1238 1240
81. E.M. Nabel, and H. Morishita Regulating critical period plasticity: insight from the visual system to fear circuitry for therapeutic interventions Front. Psychiatry 4 2013 146
82. N.C. Kim, and G. Marqués The Ly6 neurotoxin-like molecule target of wit regulates spontaneous neurotransmitter release at the developing neuromuscular junction in Drosophila Dev. Neurobiol. 72 2012 1541 1558
83. M.S. Thomsen Expression of the Ly-6 family proteins Lynx1 and Ly6H in the rat brain is compartmentalized, cell-type specific, and developmentally regulated Brain Struct. Funct. 219 2014 1923 1934
84. W.A. Nichols Lynx1 shifts α4β2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum J. Biol. Chem. 289 2014 31423 31432
85. P. Song Activated cholinergic signaling provides a target in squamous cell lung carcinoma Cancer Res. 68 2008 4693 4700
86. X.W. Fu The ly-6 protein, lynx1, is an endogenous inhibitor of nicotinic signaling in airway epithelium J. Physiol. Lung Cell. Mol. Physiol. 303 2012 L661 L668
87. C.M. McCann The cholinergic antagonist α-bungarotoxin also binds and blocks a subset of GABA receptors Proc. Natl. Acad. Sci. U.S.A. 103 2006 5149 5154
88. E.N. Lyukmanova NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1 J. Biol. Chem. 286 2011 10618 10627
89. K.J. Leath High-resolution structures of bacterially expressed soluble human CD59 Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 63 2007 648 652
90. B. Kieffer Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins Biochemistry 33 1994 4471 4482
91. Y. Huang Insights into the human CD59 complement binding interface toward engineering new therapeutics J. Biol. Chem. 280 2005 34073 34079
92. Y. Huang Defining the CD59-C9 binding interaction J. Biol. Chem. 281 2006 27398 273404
93. S. Johnson Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59 Cell Rep. 3 2013 1369 1377
94. P. Llinas Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J. 24 2005 1655 1663
95. C. Barinka Structural basis of interaction between urokinase-type plasminogen activator and its receptor J. Mol. Biol. 363 2006 482 495
96. Q. Huai Structure of human urokinase plasminogen activator in complex with its receptor Science 311 2006 656 659
97. H.D. Mertens A flexible multidomain structure drives the function of the urokinase-type plasminogen activator receptor (uPAR) J. Biol. Chem. 287 2012 34304 34315
98. X. Xu Crystal structure of the urokinase receptor in a ligand-free form J. Mol. Biol. 416 2012 629 641
99. I.E. Kasheverov Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors Curr. Pharm. Des. 15 2009 2430 2452
100. L. Moise NMR structural analysis of α-bungarotoxin and its complex with the principal α-neurotoxin-binding sequence on the α7 subunit of a neuronal nicotinic acetylcholine receptor J. Biol. Chem. 277 2002 12406 12417
101. M. Harel The binding site of acetylcholine receptor as visualized in the X-Ray structure of a complex between alpha-bungarotoxin and a mimotope peptide Neuron 32 2001 265 275
102. J.M. Miwa, and A. Walz Enhancement in motor learning through genetic manipulation of the Lynx1 gene PLoS ONE 7 2012 e43302
103. E.N. Lyukmanova Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors J. Biol. Chem. 288 2013 15888 15899